Nicolas Bahler, Bioprocess Engineer SIM at CRB, was recently featured in TechnoPharm. He discusses the importance of process simulation in addressing challenges in the manufacturing of cell and gene therapies for personalized medicine. These therapies offer new possibilities for patients but come with unique complexities.
Our team of experts dive into the most impactful tools and strategies, providing today’s trailblazers with a glimpse into the opportunities that lie ahead—and a reason to continue sprinting for that horizon.
Dave DiProspero, Senior Fellow of Pharmaceutical Process, was recently featured in Pharmaceutical Technology Europe. DiProspero provides insight in the article about ensuring quality and safety within the oral solid dose manufacturing industry.
Our latest alternative proteins report finds surprises as manufacturers raise their focus on growth, achieving price parity for consumers and pursuing sustainability for their processes and facilities.
Tony Moses, Ph.D., Fellow – Product Innovation, contributes to the conversation around alternative proteins, specifically precision fermentation for lab-grown dairy, in a recent article with The Washington Post.
JP Bornholdt, Director, SlateXpace Technical Operations, will present on revolutionizing prefabrication, modular and industrialized manufacturing approaches across the AEC supply chain with a focus on pharmaceutical manufacturing.